author_facet Khera, Nandita
Albelda, Randy
Hahn, Theresa
Coronado, Diana Salas
Odejide, Oreofe O.
Soiffer, Robert J.
Abel, Gregory A.
Khera, Nandita
Albelda, Randy
Hahn, Theresa
Coronado, Diana Salas
Odejide, Oreofe O.
Soiffer, Robert J.
Abel, Gregory A.
author Khera, Nandita
Albelda, Randy
Hahn, Theresa
Coronado, Diana Salas
Odejide, Oreofe O.
Soiffer, Robert J.
Abel, Gregory A.
spellingShingle Khera, Nandita
Albelda, Randy
Hahn, Theresa
Coronado, Diana Salas
Odejide, Oreofe O.
Soiffer, Robert J.
Abel, Gregory A.
Cancer Epidemiology, Biomarkers & Prevention
Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
Oncology
Epidemiology
author_sort khera, nandita
spelling Khera, Nandita Albelda, Randy Hahn, Theresa Coronado, Diana Salas Odejide, Oreofe O. Soiffer, Robert J. Abel, Gregory A. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-17-1040 <jats:title>Abstract</jats:title> <jats:p>Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival.</jats:p> <jats:p>Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325).</jats:p> <jats:p>Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT.</jats:p> <jats:p>Conclusions: Patient-reported financial distress after HCT does not seem to adversely affect post-HCT survival.</jats:p> <jats:p>Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival. Cancer Epidemiol Biomarkers Prev; 27(3); 345–7. ©2018 AACR.</jats:p> Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival Cancer Epidemiology, Biomarkers & Prevention
doi_str_mv 10.1158/1055-9965.epi-17-1040
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE3LTEwNDA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE3LTEwNDA
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
imprint American Association for Cancer Research (AACR), 2018
imprint_str_mv American Association for Cancer Research (AACR), 2018
issn 1538-7755
1055-9965
issn_str_mv 1538-7755
1055-9965
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str khera2018financialhardshipafterhematopoieticcelltransplantationlackofimpactonsurvival
publishDateSort 2018
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
title Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_unstemmed Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_full Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_fullStr Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_full_unstemmed Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_short Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_sort financial hardship after hematopoietic cell transplantation: lack of impact on survival
topic Oncology
Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-17-1040
publishDate 2018
physical 345-347
description <jats:title>Abstract</jats:title> <jats:p>Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival.</jats:p> <jats:p>Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325).</jats:p> <jats:p>Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT.</jats:p> <jats:p>Conclusions: Patient-reported financial distress after HCT does not seem to adversely affect post-HCT survival.</jats:p> <jats:p>Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival. Cancer Epidemiol Biomarkers Prev; 27(3); 345–7. ©2018 AACR.</jats:p>
container_issue 3
container_start_page 345
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 27
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792331536420306960
geogr_code not assigned
last_indexed 2024-03-01T13:42:32.433Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Financial+Hardship+after+Hematopoietic+Cell+Transplantation%3A+Lack+of+Impact+on+Survival&rft.date=2018-03-01&genre=article&issn=1538-7755&volume=27&issue=3&spage=345&epage=347&pages=345-347&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=Financial+Hardship+after+Hematopoietic+Cell+Transplantation%3A+Lack+of+Impact+on+Survival&aulast=Abel&aufirst=Gregory+A.&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-17-1040&rft.language%5B0%5D=eng
SOLR
_version_ 1792331536420306960
author Khera, Nandita, Albelda, Randy, Hahn, Theresa, Coronado, Diana Salas, Odejide, Oreofe O., Soiffer, Robert J., Abel, Gregory A.
author_facet Khera, Nandita, Albelda, Randy, Hahn, Theresa, Coronado, Diana Salas, Odejide, Oreofe O., Soiffer, Robert J., Abel, Gregory A., Khera, Nandita, Albelda, Randy, Hahn, Theresa, Coronado, Diana Salas, Odejide, Oreofe O., Soiffer, Robert J., Abel, Gregory A.
author_sort khera, nandita
container_issue 3
container_start_page 345
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 27
description <jats:title>Abstract</jats:title> <jats:p>Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival.</jats:p> <jats:p>Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325).</jats:p> <jats:p>Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT.</jats:p> <jats:p>Conclusions: Patient-reported financial distress after HCT does not seem to adversely affect post-HCT survival.</jats:p> <jats:p>Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival. Cancer Epidemiol Biomarkers Prev; 27(3); 345–7. ©2018 AACR.</jats:p>
doi_str_mv 10.1158/1055-9965.epi-17-1040
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE3LTEwNDA
imprint American Association for Cancer Research (AACR), 2018
imprint_str_mv American Association for Cancer Research (AACR), 2018
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14
issn 1538-7755, 1055-9965
issn_str_mv 1538-7755, 1055-9965
language English
last_indexed 2024-03-01T13:42:32.433Z
match_str khera2018financialhardshipafterhematopoieticcelltransplantationlackofimpactonsurvival
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 345-347
publishDate 2018
publishDateSort 2018
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
spelling Khera, Nandita Albelda, Randy Hahn, Theresa Coronado, Diana Salas Odejide, Oreofe O. Soiffer, Robert J. Abel, Gregory A. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-17-1040 <jats:title>Abstract</jats:title> <jats:p>Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival.</jats:p> <jats:p>Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325).</jats:p> <jats:p>Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT.</jats:p> <jats:p>Conclusions: Patient-reported financial distress after HCT does not seem to adversely affect post-HCT survival.</jats:p> <jats:p>Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival. Cancer Epidemiol Biomarkers Prev; 27(3); 345–7. ©2018 AACR.</jats:p> Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival Cancer Epidemiology, Biomarkers & Prevention
spellingShingle Khera, Nandita, Albelda, Randy, Hahn, Theresa, Coronado, Diana Salas, Odejide, Oreofe O., Soiffer, Robert J., Abel, Gregory A., Cancer Epidemiology, Biomarkers & Prevention, Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival, Oncology, Epidemiology
title Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_full Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_fullStr Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_full_unstemmed Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_short Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
title_sort financial hardship after hematopoietic cell transplantation: lack of impact on survival
title_unstemmed Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
topic Oncology, Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-17-1040